前收市價 | 7.22 |
開市 | 8.47 |
買盤 | 0.00 |
賣出價 | 0.00 |
拍板 | 19.00 |
到期日 | 2024-07-05 |
今日波幅 | 7.22 - 8.52 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
The biotech stock is feeling the heat from an indictment of a former consultant.
A federal indictment accuses a Cassava Sciences advisor of faking data to secure NIH grants. The company also faces shareholder suits.
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?